Montelukast Aurobindo (Montelukast)

Montelukast works by selectively blocking the cysteinyl leukotriene receptor CysLT1 on airway cells. This inhibition prevents leukotriene‑mediated bronchoconstriction, mucus production, and inflammatory cell recruitment, thereby reducing airway swelling and hyper‑responsiveness associated with asthma and allergic conditions.

The dosage of Montelukast Aurobindo is determined by the prescribing clinician based on the patient’s age, weight, severity of disease, and other clinical factors. Only a qualified healthcare provider can set the appropriate dose and dosing schedule.

Safety data for montelukast in pregnancy and lactation are limited. The prescriber should weigh the potential benefits against any possible risks and discuss these considerations with the patient before initiating therapy.

To request Montelukast Aurobindo, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Montelukast belongs to the leukotriene receptor antagonist class, offering an oral option that targets leukotriene‑mediated inflammation. Unlike inhaled corticosteroids or short‑acting bronchodilators, it does not provide immediate bronchodilation but is useful for long‑term control and for patients who cannot tolerate inhaled steroids.

Montelukast Aurobindo tablets should be stored at room temperature, below 25 °C, in the original packaging. Keep them away from moisture, direct sunlight and excessive heat to maintain product stability.

Montelukast Aurobindo is taken orally, usually as a tablet swallowed whole with water. It can be taken with or without food, and the exact timing (e.g., morning or evening) should follow the prescriber’s instructions.

Serious risks include rare but severe allergic reactions such as angioedema, neuropsychiatric events like depression or suicidal thoughts, and hepatic injury. Patients should seek immediate medical attention if they experience swelling of the face or throat, mood changes, or signs of liver dysfunction.

Montelukast Aurobindo should be avoided in individuals with known hypersensitivity to montelukast or any of the tablet’s excipients. It is also contraindicated in patients who have experienced severe allergic reactions to leukotriene receptor antagonists.